Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry
Nicholas A. Kolaitis, Roham T. Zamanian, Vinicio A. de Jesús Pérez, et al.
Annals of the American Thoracic Society (2020) Vol. 18, Iss. 4, pp. 613-622
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 934
Pulmonary Hypertension: A Contemporary Review
Shelsey W. Johnson, Natascha Sommer, Katherine Cox, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 208, Iss. 5, pp. 528-548
Open Access | Times Cited: 58
Treatment algorithm for pulmonary arterial hypertension
Kelly Chin, Seán Gaine, Christian Gerges, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 4, pp. 2401325-2401325
Open Access | Times Cited: 30
Investigating the “sex paradox” in pulmonary arterial hypertension: Results from the Pulmonary Hypertension Association Registry (PHAR)
Jacqueline T. DesJardin, Noah Kime, Nicholas A. Kolaitis, et al.
The Journal of Heart and Lung Transplantation (2024) Vol. 43, Iss. 6, pp. 901-910
Open Access | Times Cited: 12
Global, regional, and national burden of pulmonary arterial hypertension, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Peter J. Leary, Megan Lindstrom, Catherine O. Johnson, et al.
The Lancet Respiratory Medicine (2024)
Open Access | Times Cited: 12
Nupr1-mediated vascular smooth muscle cell phenotype transformation involved in methamphetamine induces pulmonary hypertension
Jie Zhou, Dan Guo, Zhenzhen Xu, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 7
Drugs of Misuse: Focus on Vascular Dysfunction
Holly R. Middlekauff, Ziva D. Cooper, Sasha B. Strauss
Canadian Journal of Cardiology (2022) Vol. 38, Iss. 9, pp. 1364-1377
Open Access | Times Cited: 26
Pulmonary artery compliance in different forms of pulmonary hypertension
Amber McCormick, Amita Krishnan, David B. Badesch, et al.
Heart (2023) Vol. 109, Iss. 14, pp. 1098-1105
Closed Access | Times Cited: 11
Trends in pulmonary arterial hypertension: insights from Global Burden of Disease 1990–2021
Xu Wu, Shuwei Suo, Xian Su, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e095348-e095348
Open Access
Effect of amphetamines on blood pressure
Magnus Chan, Jocelyn Chan, James M Wright
Cochrane library (2025) Vol. 2025, Iss. 3
Closed Access
Successful treatment of pulmonary hypertension due to HIV infection and amphetamine snorting: a case report
Cuiming Sun, Ying Wen, Yanli Chen
Frontiers in Medicine (2025) Vol. 12
Open Access
Methamphetamine‐Associated Pulmonary Arterial Hypertension Is Associated With Worse Right Ventricular Function Than Idiopathic Pulmonary Arterial Hypertension: A Matched Study
Eileen O’Neill, Dai‐Yin Lu, Satvik Ramakrishna, et al.
Echocardiography (2025) Vol. 42, Iss. 5
Open Access
CircRNA-Based AntimiR Therapy: A Novel Approach to Hypertension Treatment
Vahideh Tarhriz, Kamran Hosseini, Leila Abkhooie, et al.
Non-coding RNA Research (2025)
Open Access
Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension
Prangthip Charoenpong, Nicole Hall, Courtney M. Keller, et al.
CHEST Journal (2024) Vol. 165, Iss. 6, pp. 1518-1533
Closed Access | Times Cited: 3
Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants
Jeff Min, Dina Appleby, Robyn L. McClelland, et al.
Annals of the American Thoracic Society (2021) Vol. 19, Iss. 6, pp. 952-961
Open Access | Times Cited: 20
HIV-associated Pulmonary Arterial Hypertension: A Report from the Pulmonary Hypertension Association Registry
Nicholas A. Kolaitis, Matthew R. Lammi, Sula Mazimba, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 205, Iss. 9, pp. 1121-1124
Closed Access | Times Cited: 13
Social determinants of health in pulmonary arterial hypertension patients in the United States: Clinician perspective and health policy implications
Vijay R. Nadipelli, Jean Elwing, Willie H. Oglesby, et al.
Pulmonary Circulation (2022) Vol. 12, Iss. 3
Open Access | Times Cited: 13
Regional Variation in Pulmonary Arterial Hypertension in the United States: The Pulmonary Hypertension Association Registry
Connor Fling, Teresa De Marco, Noah Kime, et al.
Annals of the American Thoracic Society (2023) Vol. 20, Iss. 12, pp. 1718-1725
Closed Access | Times Cited: 7
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)
Prangthip Charoenpong, Navneet K. Dhillon, Kevin S. Murnane, et al.
BMJ Open Respiratory Research (2023) Vol. 10, Iss. 1, pp. e001917-e001917
Open Access | Times Cited: 5
Coumarin-based turn-on fluorescence probe with a large Stokes shift for detection of endogenous neutrophil elastase in live cells and zebrafish
Qi Sun, Xiang Li, Yun Guo, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2022) Vol. 281, pp. 121563-121563
Closed Access | Times Cited: 8
Methamphetamine-associated pulmonary arterial hypertension
Nicholas A. Kolaitis, Rajan Saggar, Teresa De Marco
Current Opinion in Pulmonary Medicine (2022) Vol. 28, Iss. 5, pp. 352-360
Closed Access | Times Cited: 8
Right Ventricular Failure and Pulmonary Hypertension
Sara E. Crager, Caroline Humphreys
Emergency Medicine Clinics of North America (2022) Vol. 40, Iss. 3, pp. 519-537
Closed Access | Times Cited: 7
Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension
Jianying Deng
Journal of Cardiothoracic Surgery (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 9
Anesthetic management of a patient with methamphetamine-associated pulmonary arterial hypertension undergoing laparoscopic cholecystectomy
Kensuke Oshita, Shin Tokuyama, Shosaburo Jotaki, et al.
JA Clinical Reports (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Associations and relative risks of pulmonary hypertension and lung diseases in individuals with methamphetamine use disorder
Su‐Chen Fang, Cheng-Yi Huang, Sheng‐Miauh Huang, et al.
Pulmonology (2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top